NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 1,002.70
-17.00 (-1.67%)
At close: Mar 9, 2026
NATCO Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 179,593 | 143,064 | 170,522 | 102,795 | 138,013 | 150,529 | Upgrade
|
| Market Cap Growth | 2.84% | -16.10% | 65.89% | -25.52% | -8.31% | 63.54% | Upgrade
|
| Enterprise Value | 150,201 | 120,583 | 160,841 | 93,605 | 133,992 | 144,005 | Upgrade
|
| Last Close Price | 1002.70 | 794.13 | 942.05 | 551.35 | 733.45 | 796.56 | Upgrade
|
| PE Ratio | 11.53 | 7.59 | 12.28 | 14.37 | 81.18 | 34.14 | Upgrade
|
| Forward PE | 21.24 | 7.58 | 11.66 | 10.02 | 16.05 | 26.55 | Upgrade
|
| PS Ratio | 3.94 | 3.23 | 4.26 | 3.80 | 7.09 | 7.32 | Upgrade
|
| PB Ratio | 2.08 | 1.88 | 2.91 | 2.11 | 3.24 | 3.65 | Upgrade
|
| P/TBV Ratio | 2.14 | 1.95 | 3.01 | 2.19 | 3.34 | 3.66 | Upgrade
|
| P/FCF Ratio | - | 11.04 | 19.55 | 14.63 | - | 340.56 | Upgrade
|
| P/OCF Ratio | - | 8.43 | 14.07 | 12.11 | 296.80 | 50.38 | Upgrade
|
| PEG Ratio | - | 0.25 | 0.46 | 0.20 | 0.24 | 0.44 | Upgrade
|
| EV/Sales Ratio | 3.29 | 2.72 | 4.02 | 3.46 | 6.89 | 7.00 | Upgrade
|
| EV/EBITDA Ratio | 8.35 | 5.62 | 9.19 | 9.68 | 51.54 | 23.74 | Upgrade
|
| EV/EBIT Ratio | 9.28 | 6.13 | 10.24 | 11.56 | 108.58 | 29.19 | Upgrade
|
| EV/FCF Ratio | - | 9.31 | 18.44 | 13.32 | - | 325.80 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.07 | 0.04 | 0.10 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.13 | 0.22 | 0.18 | 1.64 | 0.47 | Upgrade
|
| Debt / FCF Ratio | - | 0.22 | 0.44 | 0.25 | - | 6.42 | Upgrade
|
| Net Debt / Equity Ratio | -0.34 | -0.29 | -0.17 | -0.13 | -0.08 | -0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.65 | -1.03 | -0.57 | -0.64 | -1.26 | -0.88 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.71 | -1.15 | -0.88 | 1.76 | -12.08 | Upgrade
|
| Asset Turnover | - | 0.57 | 0.64 | 0.50 | 0.39 | 0.44 | Upgrade
|
| Inventory Turnover | - | 0.89 | 0.94 | 0.78 | 0.66 | 0.66 | Upgrade
|
| Quick Ratio | - | 4.07 | 2.73 | 2.47 | 2.02 | 2.48 | Upgrade
|
| Current Ratio | - | 5.59 | 4.14 | 4.39 | 3.50 | 4.46 | Upgrade
|
| Return on Equity (ROE) | - | 27.97% | 25.88% | 15.66% | 4.05% | 11.19% | Upgrade
|
| Return on Assets (ROA) | - | 15.82% | 15.63% | 9.40% | 1.56% | 6.57% | Upgrade
|
| Return on Invested Capital (ROIC) | 23.50% | 31.53% | 28.62% | 16.41% | 2.76% | 11.07% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 25.60% | 26.50% | 16.30% | 2.80% | 11.60% | Upgrade
|
| Earnings Yield | 8.67% | 13.18% | 8.14% | 6.96% | 1.23% | 2.93% | Upgrade
|
| FCF Yield | - | 9.06% | 5.12% | 6.84% | -1.35% | 0.29% | Upgrade
|
| Dividend Yield | 0.49% | 0.76% | 1.01% | 1.00% | 0.61% | 0.66% | Upgrade
|
| Payout Ratio | 5.75% | 5.72% | 12.30% | 14.04% | 48.35% | 25.83% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.21% | 1.67% | -0.08% | 0.04% | -0.02% | Upgrade
|
| Total Shareholder Return | 0.49% | 0.97% | 2.68% | 0.92% | 0.66% | 0.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.